BioSpace News Archive

Isofol Medical AB, announces that the recruitment and treatment of patients in the company’s Phase 1/2a study with arfolitixorin has been completed.

10 New launches at MEDLAB ME exhibition positions Erba as a complete end-to-end provider.

2019 delivered the strongest financial results for Orexo, with the fourth quarter being no exception.

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will release fourth-quarter and full-year 2019 financial results before the market opens on Thursday, February 13, 2020, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

Inovio Pharmaceuticals, Inc. announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development in China of INO-4800, Inovio’s vaccine against the recently emerged strain of coronavirus that has killed numerous people and infected thousands more in China to date.

Best Medical International and Best Particle Therapy of TeamBest Companies, have recently entered into a Memorandum of Understanding with the University of Wisconsin Medical Radiation Research Center.

Samsung Ventures has invested in the Danish company INFUSER. The cleantech company offers a unique technology that can revolutionize air purification

AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2020 first quarter ended December 31, 2019, revenue increased 5.4 percent to $47.9 billion.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that it will hold its fiscal second-quarter 2020 sales and earnings conference call with investors and analysts at 4:30 p.m. ET on Thursday, February 6, 2020.

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), today announced that it will issue financial results for its fiscal quarter ended December 31, 2019 on Thursday, February 6th, 2020.